Clinical Trials Logo

Clinical Trial Summary

assess the effectiveness of peri-capsular nerve group block and scaitico femoral block in the incidence of post amputation syndrome in patients undergoing above knee amputation.


Clinical Trial Description

The loss of a body part can lead to pain and other sensations that fall into three distinct descriptive categories, namely phantom sensations, phantom pain, and residual pain. Phantom sensations are defined as pain-free perceptions emanating from the lost body part after deafferentation, and phantom pain is a painful or unpleasant sensation in the distribution of the lost or deafferented body part 5. Phantom sensations can be a different expression of phantom pain and interfere with rehabilitation therapy by enhancing and interacting with phantom pain. The current standard of care is pre-operative nerve blockade to prevent peripheral sensitization leading to future onset of phantom limb pain. Successful outcomes necessitate effective communication between the surgeon, anesthesiologist, and the various teams involved in the post-operative rehabilitation of the patient. A consultation with the Acute Pain Service or similar entity that performs peripheral nerve blockade pre-operatively and then follows the patient during their post-operative inpatient course is an important factor in the success in early prevention of acute and chronic pain for these patients. Pericapsular nerve group block or PENG block is a novel regional nerve block to provide analgesia in fractured hip patients. It is primarily an ultrasound-guided (USG) technique where target area is the pelvic rim (superior pubic ramus) near iliopectineal eminence, deep to fascia of iliopsoas muscle. Articular branches of femoral nerve and accessory obturator nerves, which cross over the bony rim, are primary targets of the PENG block.however, by increasing volume of local anesthetic drug; other nerves (obturator, femoral, genitofemoral, and lateral femoral cutaneous nerve) can be blocked. This block is a new regional anesthesia technique based on blocking the femoral nerve (FN) and accessory obturator nerve (ON) with a single injection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05819879
Study type Interventional
Source National Cancer Institute, Egypt
Contact
Status Recruiting
Phase N/A
Start date June 10, 2023
Completion date September 20, 2023

See also
  Status Clinical Trial Phase
Completed NCT05515718 - Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures N/A
Not yet recruiting NCT06045884 - FNB in Meniscal Tear Under GA N/A
Not yet recruiting NCT06048874 - FNB in ACL Recon Under SA N/A
Not yet recruiting NCT06048341 - FNB in Meniscal Tear Under SA N/A
Not yet recruiting NCT06048848 - FNB in ACL Recon Under GA N/A
Completed NCT04642651 - Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty Phase 4
Completed NCT02125903 - Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy N/A
Completed NCT03203967 - Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty N/A
Recruiting NCT02721290 - Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using Two Femoral Block Techniques N/A
Completed NCT02089932 - Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block. Phase 4